Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010:596:123-39.
doi: 10.1007/978-1-60761-416-6_7.

Flow cytometric evaluation of multidrug resistance proteins

Affiliations
Review

Flow cytometric evaluation of multidrug resistance proteins

Adorjan Aszalos et al. Methods Mol Biol. 2010.

Abstract

There are several ways to detect proteins on cells. One quite frequently used method is flow cytometry. This method needs fluorescently labeled antibodies that can attach selectively to the protein to be investigated for flow cytometric detection. Flow cytometry scans individual cells, virtually without their surrounding liquid, and can scan many cells in a very short time. Because of this advantage of flow cytometry, it was adapted to investigate transport proteins on normal and cancerous human cells and cell lines. These transport proteins play important roles in human metabolism. Absorption in the intestine, excretion at the kidney, protection of the CNS compartment and the fetus from xenobiotics, and other vital functions depend on these transporters. However, several transporters are overexpressed in cancer cells. These overexpressed transporters pump out anticancer drugs from the cells and prevent their curative effects. The detection and quantitation of these types of transporters in cancer cells is important for this reason. Here, we review literature on flow cytometric detection of the three most studied transporters: P-glycoprotein, multidrug resistance-associated proteins, and breast cancer resistance protein.

PubMed Disclaimer

Figures

Fig. 7.1.
Fig. 7.1.
Primary structure of P-glycoprotein as positioned in cell membrane, with three antibodies (MRK16, UIC-2, and 17F9) positioned at the known binding epitopes (Adapted from Ambudkar et al. (2003) P-glycoprotein: from genomics to mechanism. Oncogene 22:7468–7485, with permission of the author).
Fig. 7.2.
Fig. 7.2.
Differences in histogram intensity after binding anti-mouse FITC, MRK16-FITC, or MRK-16 + anti-mouse FITC to P-glycoprotein-expressing NIH3T3MDR cells (From Aszalos and Weaver (1998) Estimation of drug resistance by flow cytometry. In: Jaroszeski and Heller (eds) Flow cytometry protocols. Humana, Totowa, NJ, pp 117–122, Figure 2, p. 121, with kind permission of Springer Science).
Fig. 7.3.
Fig. 7.3.
Influence of inhibitors on the side population of A549 cells stained with Hoechst 33342 dye (From Scharenberg et al. (2002) The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99:507–512, used by permission).

Similar articles

Cited by

References

    1. Schinkel AH, Jonker JW (2003) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 55:3–29 - PubMed
    1. Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5:219–234 - PubMed
    1. Aleman C, Annereau JP, Liang XJ et al. (2003) P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential. Cancer Res 63:3084–3091 - PubMed
    1. Broxterman HJ, Lankelma J, Pinedo HM et al. (1997) Theoretical and practical considerations for the measurement of P-glycoprotein function in acute myeloid leukemia. Leukemia 11:1110–1118 - PubMed
    1. Broxterman HJ, Lankelma J, Pinedo HM (1996) How to probe clinical tumour samples for P-glycoprotein and multidrug resistance-associated protein. Eur J Cancer 32A:1024–1033 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources